Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 44, Issue 11, 2004, Pages 2125-2132

  Maron, Barry J ^a   Seidman, J G ^a,b   Seidman, Christine E ^a,b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC PROCEDURE; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL ASSESSMENT; MEDICAL PRACTICE; MEDICAL SPECIALIST; ONSET AGE; PATIENT COUNSELING; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; REVIEW; SCREENING TEST;

AGE OF ONSET; CARDIOMYOPATHY, HYPERTROPHIC; CLINICAL PROTOCOLS; DNA MUTATIONAL ANALYSIS; GENETIC COUNSELING; GENOTYPE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PHENOTYPE;

EID: 4344705206     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.08.052     Document Type: Review

References (92)

1. J.G. Seidman, C.E. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104; 2001 557 567
2. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
3. A.J. Marian, R. Roberts Recent advances in the molecular genetics of hypertrophic cardiomyopathy Circulation 92 1995 1336 1347
4. K. Schwartz, L. Carrier, P. Guicheney Molecular basis of familial cardiomyopathies Circulation 91 1995 532 540
5. B.J. Maron Hypertrophic cardiomyopathy Lancet 350 1997 127 133
6. B.J. Maron, J.H. Moller, C.E. Seidman Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome Circulation 98 1998 1460 1471
7. L. Thierfelder, H. Watkins, C. MacRae Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere Cell 77; 1994 701 712
8. H. Watkins, W.J. McKenna, L. Thierfelder Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy N Engl J Med 332 1995 1058 1064
9. P. Spirito, C.E. Seidman, W.J. McKenna, B.J. Maron Management of hypertrophic cardiomyopathy N Engl J Med 30 1997 775 785
10. B.J. Maron, G.K. Danielson, Kappenberger American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference J Am Coll Cardiol 42 2003 1687 1713
11. B.J. Maron, P.F. Nichols, L.W. Pickle, Y.E. Wesley, J.J. Mulvihill Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography Am J Cardiol 53 1984 1087 1094
12. H. Watkins, A. Rosenzweig, D.-S. Hwang Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy N Engl J Med 326 1992 1108 1114
13. H. Watkins Sudden death in hypertrophic cardiomyopathy (editorial) N Engl J Med 372 2000 422 423
14. D.A. Coviello, B.J. Maron, P. Spirito Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene J Am Coll Cardiol 29; 1997 635 640
15. R. Anan, G. Greve, L. Thierfelder Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy J Clin Invest 93 1994 208-5
16. A. Rosenzweig, H. Watkins, D.-S. Hwang Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes N Engl J Med 325 1991 1753 1760
17. A. Kimura, H. Harada, J.E. Park Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy Nat Genet 16 1997 379 382
18. P. Charron, O. Dubourg, M. Desnos Genotype-phenotype correlations in familial hypertrophic cardiomyopathy associated: a comparison between mutations in the cardiac protein-C and the β-myosin heavy chain gene Eur Heart J 19 1998 139 145
19. A.A. Hagege, O. Dubourg, M. Desnos Familial hypertrophic cardiomyopathy Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy Eur Heart J 19 1998 490 499
20. J. Moolman, V.A. Corfield, B. Posen Sudden death due to troponin T mutations J Am Coll Cardiol 29 1997 549 555
21. B.J. Maron, H. Niimura, S.A. Casey Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C mutations J Am Coll Cardiol 38 2001 315 321
22. P. Charron, O. Dubourg, M. Desnos Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene Circulation 97 1998 2230 2236
23. J. Erdmann, J. Raible, J. Maki-Abadi Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy J Am Coll Cardiol 38 2001 322 330
24. P. Charron, O. Dubourg, M. Desnos Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population Circulation 96 1997 214 219
25. K. Poetter, H. Jiang, S. Hassanzadeh Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle Nat Genet 13 1996 63 69
26. J. Mogensen, I.C. Klausen, A.K. Pedersen Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy J Clin Invest 103 1999 R39 43
27. H. Watkins, L. Thierfelder, D.S. Hwang Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations J Clin Invest 90 1992 1666 1671
28. H. Niimura, L.L. Bachinski, S. Sangwatanaroj Mutations in the gene for human cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy N Engl J Med 338 1998 1248 1257
29. P. Richard, P. Charron, L. Carrier Hypertrophic cardiomyopathy Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy Circulation 107 2003 2227 2232
30. P. Jaaskelainen, M. Soranta, R. Miettinen The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population J Am Coll Cardiol 32 1998 1709 1716
31. K. Yamauchi-Takihara, C. Nakajima-Taniguchi, H. Matsui Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene Heart 76 1996 63 65
32. M. Satoh, M. Takahashi, T. Sakamoto, M. Hiroe, F. Marumo, A. Kimura Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene Biochem Biophys Res Commun 262 1999 411 417
33. J. Flavigny, P. Richard, R. Isnard Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy J Mol Med 76 1998 208 214
34. G. Bonne, L. Carrier, P. Richard Familial hypertrophic cardiomyopathy: from mutations to functional defects Circ Res 83 1998 579 593
35. B. Yu, J.A. French, L. Carrier Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene J Med Genet 35 1998 205 210
36. A. Woo, H. Rakowski, J.C. Liew Mutations of the β-myosin chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis Heart 89 2003 1179 1185
37. B.J. Maron, J.M. Gardin, J.M. Flack Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study Circulation 92 1995 785 789
38. Y. Zou, L. Song, Z. Wang Prevalence of idiopathic hypertrophic cardiomyopathy in Chinese--a cross-sectional population based echocardiographic analysis of 8080 adults Am J Med 116 2004 14 18
39. B.J. Maron Hypertrophic cardiomyopathy: an important global disease (editorial) Am J Med 116 2004 63 66
40. Y. Hada, T. Sakamoto, K. Amano Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening Am J Cardiol 59 1987 183 184
41. B.J. Maron, R. Mathenge, S.A. Casey, L.C. Poliac, T.F. Longe Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities J Am Coll Cardiol 33 1999 1590 1595
42. B.J. Maron, N.A.M. Estes III, M.S. Maron, A.K. Almquist, M.S. Link, J. Udelson Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy Circulation 107 2003 2872 2875
43. B.J. Maron, E.E. Peterson, M.S. Maron, J.E. Peterson Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study Am J Cardiol 73 1994 577 580
44. E. Braunwald, C.T. Lambrew, D. Rockoff Idiopathic hypertrophic subaortic stenosis: I A description of the disease based upon an analysis of 64 patients Circulation 30 Suppl IV 1964 3 217
45. E.D. Wigle, Z. Sasson, M.A. Henderson Hypertrophic cardiomyopathy The importance of the site and the extent of hypertrophy. A review Prog Cardiovasc Dis 28 1985 1 83
46. A.A.T. Geisterfer-Lowrance, S. Kass, G. Tanigawa, H.-P. Vosberg, W.J. McKenna, C.E. Seidman, J.G. Seidman A molecular basis of familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation Cell 62 1990 999 991006
47. A.J. Marian On predictors of sudden cardiac death in hypertrophic cardiomyopathy (editorial) J Am Coll Cardiol 41 2003 994 996
48. S.L. Van Driest, M.J. Ackerman, S.R. Ommen Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy Circulation 106 2002 3085 3090
49. M.J. Ackerman, S.L. Van Driest, S.R. Ommen Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective J Am Coll Cardiol 39 2002 2042 2048
50. B.J. Maron, W.-K. Shen, M.S. Link Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 2000 365 373
51. E. Blair, C. Redwood, O.M. de Jesus Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy Circ Res 90 2002 263 269
52. Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2004. In press.
53. J.G. Crilley, E.A. Boehm, E. Blair Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy J Am Coll Cardiol 41 2003 1776 1782
54. M. Arad, D.W. Benson, A.R. Perez-Atayde Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy J Clin Invest 109 2002 357 362
55. E. Blair, C. Redwood, H. Ashrafian Mutations in the gamma(-2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis Hum Mol Genet 10 2001 1215 1220
56. M.H. Gollob, M.S. Green, A.S.-L. Tang Identification of a gene responsible for familial Wolff-Parkinson-White syndrome N Engl J Med 344 2001 1823 1831
57. B.J. Maron, S.A. Casey, L.C. Poliac, T.E. Gohman, A.K. Almquist, D.M. Aeppli Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281; 1999 650 655
58. H.G. Klues, A. Schiffers, B.J. Maron Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients J Am Coll Cardiol 26 1995 1699 1708
59. C. Rickers, N.M. Wilkie, S.A. Casey Identification of hypertrophic cardiomyopathy by magnetic resonance imaging in the absence of echocardiographic diagnosis (abstr) Circulation 106 2002 II652 3
60. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
61. B.J. Maron, S.E. Epstein Hypertrophic cardiomyopathy: a discussion of nomenclature Am J Cardiol 43 1979 1242 1244
62. B.J. Maron, A. Pelliccia, P. Spirito Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy Circulation 91 1995 1596 1601
63. J.F. Lewis, B.J. Maron Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening Am J Cardiol 65 1990 874 881
64. A.M. Varnava, P.M. Elliott, C. Baboonian, F. Davison, M.J. Davies, W.J. McKenna Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease Circulation 104 2001 1380 1384
65. W.J. McKenna, P. Spirito, M. Desnos, O. Dubourg, M. Komajda Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families Heart 77 1997 130 132
66. C.Y. Ho, N.K. Sweitzer, B. McDonough Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy Circulation 105 2002 2992 2997
67. S.F. Nagueh, L.L. Bachinski, D. Meyer Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy Circulation 104 2001 128 130
68. B.J. Maron, P. Spirito, Y. Wesley, J. Arce Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy N Engl J Med 315 1986 610 614
69. J.A. Panza, T.J. Maris, B.J. Maron Development and determinants of dynamic obstruction to left ventricular outflow in young patients with hypertrophic cardiomyopathy Circulation 85 1992 1398 1405
70. B.J. Maron, A.H. Kragel, W.C. Roberts Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass Br Heart J 63 1990 308 310
71. A.I. Obaid, B.J. Maron Apical hypertrophic cardiomyopathy developing at a relatively advanced age Circulation 103 2001 1605
72. W.J. McKenna, J.T. Stewart, P. Nihoyannopoulos Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass Br Heart J 63 1990 287 290
73. J.A. Panza, B.J. Maron Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood Am J Cardiol 63 1989 1258 1265
74. B.J. Maron, P. Spirito Implications of left ventricular remodeling in hypertrophic cardiomyopathy Am J Cardiol 81 1998 1339 1344
75. C. Semsarian, J. French, R.J. Trent, D.R. Richmond, R.W. Jeremy The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy Aust N Z J Med 27 1997 51 58
76. B.J. Maron The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited (editorial) Ann Noninvas Electrocardiol 6 2001 277 279
77. B.J. Maron, A.J. Tajik, H.D. Ruttenberg Hypertrophic cardiomyopathy in infants: clinical features and natural history Circulation 65 1982 7 17
78. B.J. Maron, W.L. Henry, C.E. Clark, D.R. Redwood, W.C. Roberts, S.E. Epstein Asymmetric septal hypertrophy in childhood Circulation 53 1976 9 19
79. J.R. Skinner, A. Manzoor, A.M. Hayes, H.S. Joffe, R.P. Martin A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants Heart 77 1997 229 233
80. M.S. Schaffer, R.M. Freedom, R.D. Rowe Hypertrophic cardiomyopathy presenting before 2 years of age in 13 patients Pediatr Cardiol 4 1983 113 119
81. P. Spirito, P. Bellone, K.M. Harris, P. Bernabo, P. Bruzzi, B.J. Maron Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
82. H. Niimura, K.K. Patton, W.J. McKenna, B.J. Maron, J.G. Seidman, C.E. Seidman Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly Circulation 105 2002 446 451
83. B.J. Maron, S.A. Casey, R.G. Hauser, D.M. Aeppli Clinical course of hypertrophic cardiomyopathy with survival to advanced ages J Am Coll Cardiol 142 2003 882 888
84. J.F. Lewis, B.J. Maron Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life J Am Coll Cardiol 13 1989 36 45
85. H.M. Lever, R.F. Karam, P.J. Currie, B.P. Healy Hypertrophic cardiomyopathy in the elderly Distinctions from the young based on cardiac shape Circulation 79 1989 580 589
86. J.F. Lewis, B.J. Maron Clinical and morphologic expression of hypertrophic cardiomyopathy in patients <65 years of age Am J Cardiol 73 1994 1105 1111
87. W.P. Fay, C.P. Taliercio, D.M. Ilstrup, A.J. Tajik, B.J. Gersh Natural history of hypertrophic cardiomyopathy in the elderly J Am Coll Cardiol 16 1990 821 826
88. B.J. Maron, S.A. Casey, D.G. Hurrell, D.M. Aeppli Relation of left ventricular hypertrophy to age and gender in hypertrophic cardiomyopathy Am J Cardiol 91 2003 1195 1198
89. B.J. Maron, M. Piccininno, S.A. Casey, P. Bernabò, P. Spirito Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy Am J Cardiol 91 2003 626 628
90. Harvard Medical School-Partners Healthcare Center for Genetics and Genomics. Laboratory for Molecular Medicine: tests. Available at: http://www.hpcgg.org//LMM/tests.html. Accessed August 2004.
91. B.J. Maron, I. Olivotto, P. Spirito Epidemiology of hypertrophic cardiomyopathy-related death Revisited in a large non-referral-based patient population Circulation 102 2000 858 864
92. B.J. Maron, J.H. Mitchell 26th Bethesda Conference Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities J Am Coll Cardiol 24 1994 845 899